血管紧张素受体拮抗剂在优化简化降压治疗中的地位

被引：2

作者：

卢新政

机构：

[1] 南京医科大学第一附属医院心内科

来源：

中华高血压杂志 | 2012年 / 20卷 / 09期

关键词：

D O I：

10.16439/j.cnki.1673-7245.2012.09.017

中图分类号：

R544.1 [高血压];

学科分类号：

100201 [内科学];

摘要：

<正>高血压作为一种全球性心血管危险因素,近年仍在不断增长。2002年,中国高血压的患病率达18.8%;目前的患病率更高,患者总数可能超过2亿,合并多种危险因素的患者比例增加[1-2]。在非药物治疗基础上,降压药物如钙拮抗剂、血管紧张素转换酶抑制剂(angiotensin converting enzyme inhibitor,ACEI)、血管紧张素受体拮抗剂(angiotensin receptor blockers,ARB)、利尿剂、β受体阻滞剂等,仍是降压治疗的

引用

页码：816 / 818

页数：3

共 9 条

[1]

糖尿病患者多重心血管危险因素综合管理中国专家共识 [J].

胡大一 ;

蔡迺绳 ;

谌贻璞 ;

董吁钢 ;

高妍 ;

郭艺芳 ;

霍勇 ;

李焱 ;

李勇 ;

林善锬 ;

陆菊明 ;

潘长玉 ;

孙宁玲 ;

吴平生 ;

谢良地 ;

徐标 ;

严晓伟 ;

曾正陪 ;

张宇清 ;

周晓芳 ;

朱建华 .

中华高血压杂志, 2010, 18 (12) :1177-1183

[2]

降压治疗的总趋势:强化、优化、简化 [J].

卢新政 .

中华高血压杂志, 2009, 17 (10) :954-957

[3]

Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence.[J].Claudio Borghi;Santi Francesca.Patient Preference and Adherence.2012, defa

[4]

The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy [J].

Daskalopoulou, Stella S. ;

Khan, Nadia A. ;

Quinn, Robert R. ;

Ruzicka, Marcel ;

Mckay, Donald W. ;

Hackam, Daniel G. ;

Rabkin, Simon W. ;

Rabi, Doreen M. ;

Gilbert, Richard E. ;

Padwal, Raj S. ;

Dawes, Martin ;

Touyz, Rhian M. ;

Campbell, Tavis S. ;

Cloutier, Lyne ;

Grover, Steven ;

Honos, George ;

Herman, Robert J. ;

Schiffrin, Ernesto L. ;

Bolli, Peter ;

Wilson, Thomas ;

Feldman, Ross D. ;

Lindsay, M. Patrice ;

Hemmelgarn, Brenda R. ;

Hill, Michael D. ;

Gelfer, Mark ;

Burns, Kevin D. ;

Vallee, Michel ;

Prasad, G. V. Ramesh ;

Lebel, Marcel ;

McLean, Donna ;

Arnold, J. Malcolm O. ;

Moe, Gordon W. ;

Howlett, Jonathan G. ;

Boulanger, Jean-Martin ;

Larochelle, Pierre ;

Leiter, Lawrence A. ;

Jones, Charlotte ;

Ogilvie, Richard I. ;

Woo, Vincent ;

Kaczorowski, Janusz ;

Trudeau, Luc ;

Bacon, Simon L. ;

Petrella, Robert J. ;

Milot, Alain ;

Stone, James A. ;

Drouin, Denis ;

Lamarre-Cliche, Maxime ;

Godwin, Marshall ;

Tremblay, Guy ;

Hamet, Pavel .

CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (03) :270-287

[5]

Triple Therapy With Olmesartan Medoxomil, Amlodipine Besylate, and Hydrochlorothiazide in Adult Patients With Hypertension: The TRINITY Multicenter, Randomized, Double-Blind, 12-Week, Parallel-Group Study [J].

Oparil, Suzanne ;

Melino, Michael ;

Lee, James ;

Fernandez, Victor ;

Heyrman, Reinilde .

CLINICAL THERAPEUTICS, 2010, 32 (07) :1252-1269

[6]

Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents A Meta-Analysis [J].

Gupta, Ajay K. ;

Arshad, Shazia ;

Poulter, Neil R. .

HYPERTENSION, 2010, 55 (02) :399-407

[7]

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials [J].

Wald, David S. ;

Law, Malcolm ;

Morris, Joan K. ;

Bestwick, Jonathan P. ;

Wald, Nicholas J. .

AMERICAN JOURNAL OF MEDICINE, 2009, 122 (03) :290-300

[8]

Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, parallel-controlled, clinical trial [J].

Mao, Guangyun ;

Hong, Xiumei ;

Xing, Houxun ;

Liu, Ping ;

Liu, Haipeng ;

Yu, Yunxian ;

Zhang, Shanchun ;

Jiang, Shanqun ;

Wang, Xiaobin ;

Xu, Xiping .

NUTRITION, 2008, 24 (11-12) :1088-1096

[9]

Selected major risk factors and global and regional burden of disease [J].

Ezzati, M ;

Lopez, AD ;

Rodgers, A ;

Vander Hoorn, S ;

Murray, CJL .

LANCET, 2002, 360 (9343) :1347-1360

← 1 →